Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
49,463,144
-
Share change
-
-4,402,307
-
Total reported value
-
$80,622,456
-
Put/Call ratio
-
17%
-
Price per share
-
$1.63
-
Number of holders
-
89
-
Value change
-
-$5,927,552
-
Number of buys
-
35
-
Number of sells
-
36
Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q1 2023
As of 31 Mar 2023,
Xeris Biopharma Holdings, Inc. - COM (XERS) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,463,144 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, CAXTON CORP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Invesco Ltd., NORTHERN TRUST CORP, Redmile Group, LLC, and Tudor Investment Corp Et Al.
This page lists
89
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.